Simvastatin attenuates leukocyte recruitment in experimental bacterial meningitis

International Immunopharmacology

Volumn 9, Issue 3, 2009, Pages 371-374

  Winkler, Frank ^a   Angele, Barbara ^a   Pfister, Hans Walter ^a   Koedel, Uwe ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bacterial meningitis; Cerebrospinal fluid; HMG CoA reductase inhibitor; Hypothermia; Pleocytosis; Simvastatin

Indexed keywords

SIMVASTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL MENINGITIS; BLOOD BRAIN BARRIER; CELL COUNT; CELLULAR IMMUNITY; CEREBROSPINAL FLUID; CISTERNA MAGNA; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; EXPERIMENTAL MODEL; HYPOTHERMIA; INTRACRANIAL PRESSURE; LEUKOCYTE; MORBIDITY; MORTALITY; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; TREATMENT DURATION;

ANIMALS; BLOOD-BRAIN BARRIER; DISEASE MODELS, ANIMAL; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LEUKOCYTE COUNT; LEUKOCYTES; MENINGITIS, PNEUMOCOCCAL; MICE; SIMVASTATIN;

EID: 60249083456     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.11.019     Document Type: Article

References (28)

1. Falagas M.E., Makris G.C., Matthaiou D.K., and Rafailidis P.I. Statins for infection and sepsis: a systematic review of the clinical evidence. J Antimicrob Chemother 61 (2008) 774-785
2. Gao F., Linhartova L., Johnston A.M., and Thickett D.R. Statins and sepsis. Br J Anaesth 100 (2008) 288-298
3. Grip O., Janciauskiene S., and Lindgren S. Pravastatin down-regulates inflammatory mediators in human monocytes in vitro. Eur J Pharmacol 410 (2000) 83-92
4. Bifulco M., Malfitano A.M., and Marasco G. Potential therapeutic role of statins in neurological disorders. Expert Rev Neurother 8 (2008) 827-837
5. Chen S.F., Hung T.H., Chen C.C., Lin K.H., Huang Y.N., Tsai H.C., et al. Lovastatin improves histological and functional outcomes and reduces inflammation after experimental traumatic brain injury. Life Sci 81 (2007) 288-298
6. Greenwood J., Steinman L., and Zamvil S.S. Statin therapy and autoimmune disease: from protein prenylation to immunomodulation. Nat Rev Immunol 6 (2006) 358-370
7. Kato N., Liang Y.Q., Ochiai Y., and Jesmin S. Systemic evaluation of gene expression changes in major target organs induced by atorvastatin. Eur J Pharmacol 584 (2008) 376-389
8. Merx M.W., Liehn E.A., Graf J., van de S.A., Schaltenbrand M., Schrader J., et al. Statin treatment after onset of sepsis in a murine model improves survival. Circulation 112 (2005) 117-124
9. Yasuda H., Yuen P.S., Hu X., Zhou H., and Star R.A. Simvastatin improves sepsis-induced mortality and acute kidney injury via renal vascular effects. Kidney Int 69 (2006) 1535-1542
10. Ando H., Takamura T., Ota T., Nagai Y., and Kobayashi K. Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis. J Pharmacol Exp Ther 294 (2000) 1043-1046
11. Erkkila L., Jauhiainen M., Laitinen K., Haasio K., Tiirola T., Saikku P., et al. Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice. Antimicrob Agents Chemother 49 (2005) 3959-3962
12. de Gans J., and van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 347 (2002) 1549-1556
13. Weisfelt M., de G.J., van der P.T., and van de B.D. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol 5 (2006) 332-342
14. Koedel U., Winkler F., Angele B., Fontana A., Flavell R.A., and Pfister H.W. Role of Caspase-1 in experimental pneumococcal meningitis: evidence from pharmacologic Caspase inhibition and Caspase-1-deficient mice. Ann Neurol 51 (2002) 319-329
15. Winkler F., Koedel U., Kastenbauer S., and Pfister H.W. Differential expression of nitric oxide synthases in bacterial meningitis: role of the inducible isoform for blood-brain barrier breakdown. J Infect Dis 183 (2001) 1749-1759
16. Koedel U., Rupprecht T., Angele B., Heesemann J., Wagner H., Pfister H.W., et al. MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. Brain 127 (2004) 1437-1445
17. Koedel U., Scheld W.M., and Pfister H.W. Pathogenesis and pathophysiology of pneumococcal meningitis. Lancet Infect Dis 2 (2002) 721-736
18. Hoffmann O., Priller J., Prozorovski T., Schulze-Topphoff U., Baeva N., Lunemann J.D., et al. TRAIL limits excessive host immune responses in bacterial meningitis. J Clin Invest 117 (2007) 2004-2013
19. Pruefer D., Makowski J., Schnell M., Buerke U., Dahm M., Oelert H., et al. Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin. Circulation 106 (2002) 2104-2110
20. Diomede L., Albani D., Sottocorno M., Donati M.B., Bianchi M., Fruscella P., et al. In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products. Arterioscler Thromb Vasc Biol 21 (2001) 1327-1332
21. Maher B.M., Dhonnchu T.N., Burke J.P., Soo A., Wood A.E., and Watson R.W. Statins alter neutrophil migration by modulating cellular Rho activity-a potential mechanism for statins-mediated pleotropic effects?. J Leukoc Biol (2008)
22. Ifergan I., Wosik K., Cayrol R., Kebir H., Auger C., Bernard M., et al. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis. Ann Neurol 60 (2006) 45-55
23. Koedel U., Paul R., Winkler F., Kastenbauer S., Huang P.L., and Pfister H.W. Lack of endothelial nitric oxide synthase aggravates murine pneumococcal meningitis. J Neuropathol Exp Neurol 60 (2001) 1041-1050
24. Marfin A.A., Sporrer J., Moore P.S., and Siefkin A.D. Risk factors for adverse outcome in persons with pneumococcal pneumonia. Chest 107 (1995) 457-462
25. Sprung C.L., Peduzzi P.N., Shatney C.H., Schein R.M., Wilson M.F., Sheagren J.N., et al. Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med 18 (1990) 801-806
26. Gilden D.H., Mahalingam R., Cohrs R.J., and Tyler K.L. Herpesvirus infections of the nervous system. Nat Clin Pract Neurol 3 (2007) 82-94
27. Pfister H.W., Feiden W., and Einhaupl K.M. Spectrum of complications during bacterial meningitis in adults. Results of a prospective clinical study. Arch Neurol 50 (1993) 575-581
28. Balduini W., De A V., Mazzoni E., and Cimino M. Simvastatin protects against long-lasting behavioral and morphological consequences of neonatal hypoxic/ischemic brain injury. Stroke 32 (2001) 2185-2191